Moody’s affirms J&J’s Aaa rating
Moody’s Investors Service affirmed the ratings of Johnson & Johnson including the Aaa senior unsecured rating and the Prime-1 commercial […]
Moody’s Investors Service affirmed the ratings of Johnson & Johnson including the Aaa senior unsecured rating and the Prime-1 commercial […]
Care24, Indias leading home healthcare services provider, announced the launch of its home-based health offerings in NCR region, with a […]
Pfizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted […]
Piramal Enterprises Limited announced that its wholly owned Critical Care subsidiary in the UK has entered into an agreement to […]
Suven Life Sciences Ltd announced that the grant of one product patent from USA corresponding to the New Chemical Entities […]
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce and Industry […]
Moody’s Investors Service has revised to negative from stable the outlook on the Aa3 long-term ratings of Novartis AG (Novartis) […]
Ajanta Pharma clarified that there is no import alert by US FDA on our facility or any of our products […]
The Indian pharmaceutical industry registered a robust growth of 29 per cent in Financial Year 2015-16, as India emerged as […]
The National Pharmaceutical Pricing Authority (NPPA) has asked makers of coronary stents to disclose detailed pricing data about their products […]
Metropolis Healthcare Ltd has signed agreement with We Foundation, a NGO working towards educating, empowering and encouraging women for training […]
Hyderabad-based Indian pharmaceutical major Aurobindo Pharma has signed a 135-million euro deal to buy Generis Farmaceutica SA, a company that […]
Biocon Ltd announced that the U.S.Food and Drug Administration has accepted Mylans biologics license application for MYL- 1401O. Dr Arun […]